Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glimepiride, quantity: 3 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; iron oxide yellow; sodium starch glycollate; microcrystalline cellulose; povidone - indications: amaryl is indicated as an adjunct to diet, exercise and weight loss to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glibenclamide, quantity: 5 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; pregelatinised maize starch; lactose monohydrate; purified talc; maize starch - daonil and semi-daonil are indicated as an adjunct to diet to lower the blood glucose in patients with non-insulin-dependent diabetes mellitus (type 2) whose hyperglycaemia cannot be controlled by diet alone. because of its broad and predictable action, daonil and semi-daonil are often suitable for the management of patients who have failed to respond to other oral antidiabetics.,in initiating treatment for non-insulin-dependent diabetes, diet should be emphasised as the primary form of treatment. caloric restriction and weight loss are essential in the obese diabetic patient. proper dietary management alone may be effective in controlling the blood glucose and symptoms of hyperglycaemia. the importance of regular physical activity should also be stressed, and cardiovascular risk factors should be identified and corrective measures taken where possible. if this treatment programme fails to reduce symptoms and/or blood glucose the use of an oral sulphonylurea should be considered. use of daonil and semi-daonil must be viewed by both the physician and patient as a treatment in addition to diet, and not as a substitute for diet or as a convenient mechanism for avoiding dietary restraint.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glimepiride, quantity: 4 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; sodium starch glycollate; povidone; indigo carmine; lactose monohydrate - amaryl is indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glimepiride, quantity: 2 mg - tablet, uncoated - excipient ingredients: indigo carmine; sodium starch glycollate; lactose monohydrate; povidone; iron oxide yellow; magnesium stearate; microcrystalline cellulose - amaryl is indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glimepiride, quantity: 1 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; sodium starch glycollate; lactose monohydrate; povidone; iron oxide red - amaryl is indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 50 microgram - tablet, uncoated - excipient ingredients: sodium starch glycollate; sodium stearylfumarate; microcrystalline cellulose; light magnesium oxide - levothox is indicated for the management of demonstrated thyroid hormone deficiency.,levothox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 200 microgram - tablet, uncoated - excipient ingredients: light magnesium oxide; sodium starch glycollate; sodium stearylfumarate; microcrystalline cellulose; allura red ac aluminium lake - levothox is indicated for the management of demonstrated thyroid hormone deficiency.,levothox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 100 microgram - tablet, uncoated - excipient ingredients: sodium starch glycollate; light magnesium oxide; microcrystalline cellulose; sodium stearylfumarate; sunset yellow fcf aluminium lake; tartrazine aluminium lake - levothox is indicated for the management of demonstrated thyroid hormone deficiency.,levothox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 75 microgram - tablet, uncoated - excipient ingredients: light magnesium oxide; sodium stearylfumarate; sodium starch glycollate; microcrystalline cellulose; allura red ac aluminium lake; indigo carmine aluminium lake - levothox is indicated for the management of demonstrated thyroid hormone deficiency.,levothox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

waymade australia pty limited - levothyroxine sodium, quantity: 0.1 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sunset yellow fcf aluminium lake; magnesium stearate; colloidal anhydrous silica; quinoline yellow aluminium lake; purified talc; pregelatinised starch - thyrox is indicated for the management of demonstrated thyroid hormone deficiency.,thyrox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.